Guangmingyan-4-decoction pretreatment in carbon tetrachloride-induced liver injury in male mice with exploratory molecular profiling
Year: 2026
Type: article
Abstract: BACKGROUNDGuangmingyan-4-decoction (MD-4) is a Mongolian medicinal formula, and its effects in experimental acute liver injury have not been fully characterized. AIMTo evaluate MD-4 pretreatment in a mouse carbon tetrachloride (CCl 4 ) model and to identify candidate molecular associations. METHODSMale C57BL/6 mice were given saline or MD-4 (0.308 g/kg/day, 0.617 g/kg/day, or 1.233 g/kg/day) for seven consecutive days before CCl 4 administration.Gavage was discontinued after induction.Independent cohorts were assessed on days 2, 5, and 7 using biochemical, inflammatory, and histological endpoints.Oxidative-stress indices together with blinded P65/p-P65 immunohistochemistry were evaluated in the control, model, and medium-dose groups.Liver RNA sequencing and untargeted serum metabolomics were performed on days 2 and 5, with false discovery rate correction applied. RESULTSMD-4 pretreatment was associated with improvements across multiple liver-injury outcomes.In the medium-dose group, malondialdehyde was lower, while superoxide dismutase and glutathione were higher than in the model group at all three time points.Reactive oxygen species levels were also lower on days 2 and 5; the day-7 difference did not reach significance (adjusted P = 0.0544).P65 and p-P65 nuclear-positive rates were lower than those in the model group.Application of strict transcriptomic criteria identified 15 and 38 differentially expressed genes on days 2 and 5, respectively.No serum metabolite passed false discovery rate correction, and the PLS-DA models lacked reliable predictive support.The 4 / 42 metabolomic and cross-omics pathway findings remained exploratory.CONCLUSION MD-4 pretreatment was associated with attenuated liver injury in this male-mouse CCl 4 model.Molecular findings identify candidate associations rather than validated mediating mechanisms.Independent validation in adequately powered studies that include both sexes is required.
DOI: 10.3748/wjg.126559
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7235911949
